BioGX

Looking for ideas on how to improve your Mycobacterium testing model? Dr Yang's webinar is a great tutorial on how he integrated PCR into their workflow.

If you haven’t had a chance to watch yet, don’t miss out on the opportunity to gain valuable insights into the development and integration of PCR and NGS diagnostic testing for Mycobacterium. This session, presented by Shaun Yang, PhD, D(ABMM), MLS (ASCP) from the University of California (UCLA), Los Angeles, explores the latest advancements in these technologies. In this comprehensive session, Dr. Yang explores the cutting-edge integration of PCR (Polymerase Chain Reaction) and NGS (Next-Generation Sequencing) technologies in Mycobacterium diagnostics, including their role in improving accuracy, speed, and patient outcomes. These Speaker will cover: ? The role of PCR & NGS in improving diagnostic accuracy ? Real-world applications and case studies ? Practical applications and case studies from the clinical setting Don’t miss this opportunity to gain valuable insights and engage with leading experts in molecular diagnostics. https://lnkd.in/ghz3kkmq hashtag #PCRTesting hashtag #NGSTechnology hashtag #MolecularDiagnostics hashtag #Mycobacterium hashtag #GeneticTesting hashtag #HealthcareInnovation hashtag #MedicalDiagnostics hashtag #NextGenSequencing hashtag #ClinicalResearch hashtag #Biotech hashtag #LaboratoryMedicine hashtag #PrecisionMedicine hashtag #MedTech hashtag #MedicalWebinar hashtag #DiagnosticTechnology

??BioGX: Advancing PCR Testing for Healthcare Providers & Clinical Labs ?? In today’s fast-paced diagnostics landscape, accuracy, speed, and flexibility are critical for healthcare professionals. At BioGX, we empower clinical laboratories with real-time PCR solutions that streamline workflows and enhance patient care. ? Multi-Platform Compatibility – Works seamlessly with leading PCR instruments for greater lab efficiency. ? Lyophilized Reagents – Room-temperature stability eliminates cold storage challenges. ? Comprehensive Infectious Disease Panels – From respiratory viruses to antimicrobial resistance, we provide broad molecular detection. ? Rapid & Reliable Results – Ready-to-use assays minimize processing time and reduce lab errors. ?? From hospital labs to reference centers, BioGX delivers trusted PCR solutions to support accurate and timely patient diagnostics. ?? Learn more about our innovations:https://www.biogx.com/ Contact us to learn more @ ?? Mobile: +201004622954 ?? Email: [email protected] #MolecularDiagnostics #ClinicalLab #PCRTesting #BioGX #HealthcareInnovation #InfectiousDiseases #IST_Scientist_Hall

?? Your Research, Your Way – Custom PCR Assays by BioGX ?? At BioGX, we understand that every research journey is unique. That's why our Custom PCR Assays are tailored to meet your specific needs, ensuring precision and reliability in every step of your molecular testing process. ?? Whether it's unique targets, multiplex assays, or specialized requirements, our expert team collaborates with you to design solutions that work seamlessly with your existing platforms. ? Flexible design for specific needs ? High-quality, validated performance ? Trusted by researchers worldwide Empower your research with the confidence of assays designed just for you. ?? Explore more: https://lnkd.in/gYE6dvud please don't hesitate to contact us @ Mobile: +201004622954 Email: [email protected] #PCR #CustomAssays #BioGX #MolecularBiology #Diagnostics #IST_Scientist_Hall

As per the rapid risk assessment published by the?European Centre for Disease Prevention and Control (ECDC),?increased?bloodstream infections caused by?carbapenem-resistant?Klebsiella pneumoniae?are being reported?in?23 EU Member States due to?hyper virulent strains being spread and transmitted within hospitals and healthcare networks. This finding is also?linked?to a higher incidence of?Escherichia coli?isolates that carry?carbapenemase?genes with a risk to spread into community settings.? https://lnkd.in/gRcmP8vm Rapid detection and?characterisation?of carbapenem-resistant isolates is crucial to control and reduce the spread?in?the EU/EEA?system and to prevent community-associated transmission. BioGX offers rapid, multi-platform compatible real-time PCR testing solutions for the detection of different?carbapenemase?genes?and related pathogens. https://lnkd.in/ggeGVprJ

Don’t miss the opportunity to gain valuable insight into the development and Integration of PCR and NGS Diagnostic Testing for Mycobacterium. Presented by Shaun Yang, PhD., D(ABMM), MLS (ASCP) at University of California (UCLA), Los Angeles, United States. In this comprehensive session, Dr. Yang explores the cutting-edge integration of PCR (Polymerase Chain Reaction) and NGS (Next-Generation Sequencing) technologies in Mycobacterium diagnostics, including their role in improving accuracy, speed, and patient outcomes. These Speaker will cover: ? The role of PCR & NGS in improving diagnostic accuracy ? Real-world applications and case studies ? Practical applications and case studies from the clinical setting Don’t miss this opportunity to gain valuable insights and engage with leading experts in molecular diagnostics. ?https://lnkd.in/ghz3kkmq #PCRTesting #NGSTechnology #MolecularDiagnostics #Mycobacterium #GeneticTesting #HealthcareInnovation #MedicalDiagnostics #NextGenSequencing #ClinicalResearch #Biotech #LaboratoryMedicine #PrecisionMedicine #MedTech #MedicalWebinar #DiagnosticTechnology

?? Your Research, Your Way – Custom PCR Assays by BioGX ?? At BioGX, we understand that every research journey is unique. That's why our Custom PCR Assays are tailored to meet your specific needs, ensuring precision and reliability in every step of your molecular testing process. ?? Whether it's unique targets, multiplex assays, or specialized requirements, our expert team collaborates with you to design solutions that work seamlessly with your existing platforms. ? Flexible design for specific needs ? High-quality, validated performance ? Trusted by researchers worldwide Empower your research with the confidence of assays designed just for you. ?? Explore more: https://lnkd.in/gYE6dvud please don't hesitate to contact us @ Mobile: +201004622954 Email: [email protected] #PCR #CustomAssays #BioGX #MolecularBiology #Diagnostics #IST_Scientist_Hall

EU agencies, including the European Centre for Disease Prevention and Control (ECDC), reviewed the use of azole?fungicides?from 2010 to 2021 in the?European Union and European Economic Area (EU/EEA). Due to the high usage in?horticultural?and agricultural practices to control fungal diseases in plants, it was found that there is a link between?environmental azole exposure and resistance selection to medical azoles in Aspergillus species (primarily shown for A. fumigatus). Up to 64% of A. fumigatus isolates are resistant to azoles which is associated with severe diseases and poorer outcomes.?https://lnkd.in/gQ7Pknp5 One of the key recommendations was to?enhanced disease diagnostics, surveillance and increased awareness of this topic. BioGX offers rapid?real-time PCR testing solutions for the detection of Aspergillus spp.? https://lnkd.in/ggeGVprJ

Kansas is currently experiencing the largest tuberculosis (TB) outbreak in U.S. history, with over 200 cases identified so far. This alarming rise in cases emphasizes the need for enhanced detection and a swift, coordinated public health response. The situation serves as a reminder of the ongoing challenge infectious diseases pose, even as we’ve made significant progress in prevention and treatment. https://lnkd.in/g3yJNf-2 To better manage these threats, reliable and efficient diagnostic tools are critical. At BioGX, we offer syndromic Mycobacterium tests that enable healthcare professionals to quickly detect and respond to TB and other respiratory infections, supporting improved patient care and public health efforts. https://lnkd.in/gF7wugQf #PublicHealth #Tuberculosis #HealthcareInnovation #RespiratoryHealth #Diagnostics

Exclusive Webinar on PCR Diagnostics for Pneumocystis jirovecii! If you haven’t tuned in yet, there’s still time to watch our insightful webinar featuring experts from Cedars-Sinai Medical Center, Los Angles: Margie Morgan, PhD., D(ABMM), MT(ASCP) Deisy Contreras, PhD., D(ABMM) These Speakers will cover: ? The challenges of diagnosing Pneumocystis jirovecii. ? The development and validation of PCR diagnostic tests. ? Implications for clinical practice and patient outcomes. Don’t miss this opportunity to learn from leaders in molecular diagnostics and enhance your expertise in this critical area of healthcare. https://lnkd.in/ghz3kkmq